Impact of HPV16/18 vaccination on quality of life: A pilot study

REFERENCES

• IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007;90: 1–636.
   PubMedGoogle Scholar
• Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol 2010;117(2 Suppl.): S5–10.
   PubMed Web of Science ®Google Scholar
• Maissi E, Marteau TM, Hankins M, et al. The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up. Br J Cancer 2005;92:990–4.
   PubMed Web of Science ®Google Scholar
• Woodhall S, Ramsey T, Cai C, et al. Estimation of the impact of genital warts on health-related quality of life. Sex Transm Infect 2008;84:161–6.
   PubMed Web of Science ®Google Scholar
• Pirotta M, Ung L, Stein A, et al. The psychosocial burden of human papillomavirus related disease and screening interventions. Sex Transm Infect 2009;85:508–13.
   PubMed Web of Science ®Google Scholar
• Wang SM, Shi JF, Kang DJ, et al. Impact of human papillomavirus-related lesions on quality of life: A multicenter hospital-based study of women in mainland China. Int J Gynecol Cancer 2011;21:182–8.
   PubMed Web of Science ®Google Scholar
• Woodhall S, Eriksson T, Nykanen AM, et al. Impact of HPV vaccination on young women's quality of life – a five year follow-up study. Eur J Contracept Reprod Health Care 2011;16:3–8.
   PubMed Web of Science ®Google Scholar
• Munoz N, Kjaer SK, Sigurdsson K, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst 2010;102:325–39.
   PubMed Web of Science ®Google Scholar
• Dillner J, Arbyn M, Unger E, Dillner L. Monitoring of human papillomavirus vaccination. Clin Exp Immunol 2011;163:17–25.
   PubMed Web of Science ®Google Scholar
• Lehtinen M, Paavonen J, Wheeler CM, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012;13:89–99.
   PubMed Web of Science ®Google Scholar
• Garland SM, Hernandez-Avila M, Wheeler CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356: 1928–43.
   PubMed Web of Science ®Google Scholar
• Malagon T, Drolet M, Boily MC, et al. Cross-protective efficacy of two human papillomavirus vaccines: A systematic review and meta-analysis. Lancet Infect Dis 2012;12:781–9.
   PubMed Web of Science ®Google Scholar
• Aalto A-M, Aro AR, Teperi J. RAND-36 terveyteen liittyvän elämänlaadun mittarina. – Mittarin luotettavuus ja suomalaiset väestöarvot. [RAND-36 as a measure of Health-Related Quality of Life. Reliability, construct validity and reference values in the Finnish general population.] Helsinki: Stakes, Research Reports, vol. 101, 1999. [In Finnish].
   Google Scholar
• The EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208.
   PubMed Web of Science ®Google Scholar
• Badia X, Colombo JA, Lara N, et al. Combination of qualitative and quantitative methods for developing a new Health Related Quality of Life measure for patients with anogenital warts. Health Qual Life Outcomes 2005; 3:24–30.
   PubMedGoogle Scholar
• Lehtinen M, Apter D, Dubin G, et al. Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: Guarding against guessing. Int J STD AIDS 2006;17: 517–21.
   PubMed Web of Science ®Google Scholar
• Paavonen J, Naud P, Salmeron J, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301–14.
   PubMed Web of Science ®Google Scholar
• Sneed CD. Sexual risk behavior among early initiators of sexual intercourse. AIDS Care 2009;21:1395–400.
   PubMed Web of Science ®Google Scholar
• Hansen BT, Kjaer SK, Munk C, et al. Early smoking initiation, sexual behavior and reproductive health – a large population-based study of Nordic women. Prev Med 2010;51:68–72.
   PubMed Web of Science ®Google Scholar
• Olesen TB, Jensen KE, Nygard M, et al. Young age at first intercourse and risk-taking behaviours – a study of nearly 65 000 women in four Nordic countries. Eur J Public Health 2012;22:220–4.
   PubMed Web of Science ®Google Scholar
• IBM Corp. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp 2011.
   Google Scholar
• McHorney CA, Ware JE, Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40–66.
   Google Scholar
• Sullivan M, Karlsson J, Ware JE, Jr. The Swedish SF-36 Health Survey – I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995;41: 1349–58.
   PubMed Web of Science ®Google Scholar
• Idestrom M, Milsom I, Andersson-Ellstrom A. Women's experience of coping with a positive Pap smear: A register-based study of women with two consecutive Pap smears reported as CIN 1. Acta Obstet Gynecol Scand 2003;82:756–61.
   PubMed Web of Science ®Google Scholar